Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 207127 + BI 201335 with or without ribavirin in chronic hepatitis C genotype 1
2009-018197-66Phase 2Completed
- Sponsor
- Unilfarma
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in hepatitis C virus infection comparing BI 207127 + BI 201335 + ribavirin, BI 207127 + BI 201335 and BI 207127 + BI 201335 + ribavirin + peginterferon alfa-2a (3 arms). Started Feb 2010; status: completed.
02
Drugs
deleobuvirfaldaprevirribavirinpeginterferon alfa-2a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2009-018197-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018197-66.